Study of the use of abdominal compression elastic support (ACES) for hemodialysis patents.
Study to evaluate the long-term efficacy and safety of oral tolvaptan tablet.
PI: Charles H. Brooks, MD, MSc:
A randomized, multicenter, double-blind, placebo-controlled study of AC607 for the treatment of acute kidney injury in cardiac surgery subjects (Phase 2), AC6071103.
Phase IIb, randomized trial for acute kidney injury in high-risk major surgery.
PI: Mitchell Rosner, MD, FACP:
MD-INMD Covance, Inc. – Tolvaptan PKD-156-09-290, 156-09-29.
Kadmon Corporation, LLC; Protocol: KDo19-101.
PI: Rasheed Balogun, MD:
Protocol for tracking economic data of subjects participating in protocol VTI-208.
A randomized, open-label, multicenter, controlled study to assess safety and efficacy of ELAD® in subjects with alcohol-induced liver decompensation.
PI: Sundararaman Swaminathan, MD:
Iron export pathway as a novel target in diabetic kidney disease.
